首页> 外文期刊>International Journal of Pharmaceutics >Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation
【24h】

Solubility of crystalline organic compounds in high and low molecular weight amorphous matrices above and below the glass transition by zero enthalpy extrapolation

机译:零焓外推法计算玻璃化转变温度上下的高分子量和低分子量非晶态基质中结晶有机化合物的溶解度

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Pharmaceutical applications which require knowledge of the solubility of a crystalline compound in an amorphous matrix are abundant in the literature. Several methods that allow the determination of such data have been reported, but so far have only been applicable to amorphous polymers above the glass transition of the resulting composites. The current work presents, for the first time, a reliable method for the determination of the solubility of crystalline pharmaceutical compounds in high and low molecular weight amorphous matrices at the glass transition and at room temperature (i.e. below the glass transition temperature), respectively. The solubilities of mannitol and indomethacin in polyvinyl pyrrolidone (PVP) K15 and PVP K25, respectively were measured at different temperatures. Mixtures of undissolved crystalline solute and saturated amorphous phase were obtained by annealing at a given temperature. The solubility at this temperature was then obtained by measuring the melting enthalpy of the crystalline phase, plotting it as a function of composition and extrapolating to zero enthalpy. This new method yielded results in accordance with the predictions reported in the literature. The method was also adapted for the measurement of the solubility of crystalline low molecular weight excipients in amorphous active pharmaceutical ingredients (APIs). The solubility of mannitol, glutaric acid and adipic acid in both indomethacin and sulfadimidine was experimentally determined and successfully compared with the difference between their respective calculated Hildebrand solubility parameters. As expected from the calculations, the dicarboxylic acids exhibited a high solubility in both amorphous indomethacin and sulfadimidine, whereas mannitol was almost insoluble in the same amorphous phases at room temperature. This work constitutes the first report of the methodology for determining an experimentally measured solubility for a low molecular weight crystalline solute in a low molecular weight amorphous matrix.
机译:在文献中,需要了解结晶化合物在无定形基质中的溶解度的药物应用非常丰富。已经报道了几种可以确定这些数据的方法,但是到目前为止,仅适用于所得复合材料的玻璃化转变以上的无定形聚合物。当前的工作首次提出了一种可靠的方法,分别测定玻璃化转变温度和室温(即低于玻璃化转变温度)下结晶药物化合物在高分子量和低分子量无定形基质中的溶解度。在不同温度下分别测量了甘露醇和消炎痛在聚乙烯吡咯烷酮(PVP)K15和PVP K25中的溶解度。通过在给定温度下退火获得未溶解的结晶溶质和饱和非晶相的混合物。然后,通过测量结晶相的熔融焓,将其绘制为组成的函数并外推至零焓,来获得该温度下的溶解度。这种新方法产生的结果与文献报道的预测一致。该方法还适用于测量结晶性低分子量赋形剂在无定形活性药物成分(API)中的溶解度。实验测定了甘露醇,戊二酸和己二酸在消炎痛和磺胺二甲胺中的溶解度,并成功地与它们各自计算的希尔德布兰德溶解度参数之间的差异进行了比较。从计算中可以预期,二元羧酸在无定形消炎痛和磺胺嘧啶中均显示出高溶解度,而甘露醇在室温下几乎不溶于相同的无定形相。这项工作构成了确定低分子量无定形基质中低分子量结晶溶质的实验测量溶解度的方法的第一份报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号